Status:
TERMINATED
Exercise and Nutrition Education in Improving Physical Function and Quality of Life in Older Breast Cancer Survivors
Lead Sponsor:
Roswell Park Cancer Institute
Conditions:
Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage IA Breast Cancer AJCC v8
Eligibility:
All Genders
65+ years
Phase:
NA
Brief Summary
This trial studies how well exercise and nutrition education work in improving physical function and quality of life in older breast cancer survivors. Exercise and nutrition education may help to impr...
Detailed Description
PRIMARY OBJECTIVES: I. To assess the effect of a home-based aerobic and resistance exercise and nutrition education intervention in overweight or obese, sedentary, older (65 years and above) breast c...
Eligibility Criteria
Inclusion
- Men or women with a history of breast cancer who have completed treatment \>=3 months ago (not including hormonal therapy, Zometa, or other non-chemotherapy/radiation cancer treatment at the discretion of the principal investigator)
- Physically inactive, defined as not meeting 150 minutes or 2 hours and 30 minutes a week of vigorous-intensity exercise
- Overweight or obese, defined as having a body mass index (BMI) between 26 kg/m\^2 and 42 kg/m\^2, inclusive
- Meeting criteria for participation in low to moderate risk exercise based on the American College of Sports and Medicine (ACSM) guideline
- Providing informed consent indicating understanding the investigational nature of this study by signing an Independent Ethics Committee/Institutional Review Board approved written informed consent form prior to receiving any study related procedures
Exclusion
- Metastatic breast cancer
- Orthopedic or neuromuscular disorders that preclude participation in exercise
- Any history of myocardial infarction (MI), angina pectoris, or congestive heart failure
- High risk for moderate exercise based on ACSM risk classification
- Pregnant or nursing
- Unwilling or unable to follow protocol requirements
- Any condition which - in the investigator?s opinion - deems the participant an unsuitable candidate to participate in this study
Key Trial Info
Start Date :
March 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 21 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT03751449
Start Date
March 25 2019
End Date
May 21 2021
Last Update
June 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Roswell Park Cancer Institute
Buffalo, New York, United States, 14263